MedPath

Short Pulse and Q-switched ND-YAG Laser With Topical Carbon Versus Fractional CO2 Laser for Enlarged Facial Pores

Not Applicable
Completed
Conditions
Skin Lesion
Interventions
Device: short pulse and Q-switched ND-YAG laser with topical carbon
Device: fractional CO2 laser
Registration Number
NCT04470466
Lead Sponsor
Cairo University
Brief Summary

Facial pores are visible topographic features of the skin that reflect openings of pilosebaceous follicles, that may be enlarged causing distress to some individuals. Many patients desire treatment for this condition, which can be an early sign of skin aging. Therapeutic modalities include intense pulsed light, radiofrequency, dermabrasion, oral and topical retinoids, as well as chemical peeling. Lasers, as fractional CO2, short pulse and Q-switched Nd-YAG, can potentially be used in treatment of wide pores.

This study aims at the assessment and comparison of therapy with short pulsed and Q-switched Nd-YAG laser plus topical carbon with fractional CO2 laser in the management of wide facial pores.

Detailed Description

topical carbon cream will be applied to one side of the face in patients with wide facial pores, followed by 2 passes of short pulse 1064 ND:YAG laser, then one pass of Q-switched ND-YAG laser.

fractional CO2 laser will be performed to the other half of the face. the patients will receive 2 treatment sessions

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Participants who are more than 18 years old with the large facial pores and are aware of their problem and seeking treatment
Exclusion Criteria
  • • Previous laser therapy, chemical peeling, microdermabrasion or cosmetic procedure for the face.

    • Patients with any contraindication to laser therapy such as photosensitive diseases, skin malignancies, patients on oral retinoids.
    • Keloid-forming tendency.
    • Local or systemic treatment for skin pores in the previous 3 months
    • Connective tissue disease or the use of immunosuppressive medications.
    • Pregnancy.
    • Present or past history of herpes labialis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
short pulse and Q-switched ND-YAG laser with topical carbonshort pulse and Q-switched ND-YAG laser with topical carbon-
Fractional CO2 Laserfractional CO2 laser-
Primary Outcome Measures
NameTimeMethod
the percentage of decrease in size of enlarged facial pores assessed clinically and by dermoscopy2 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasr Alainy

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath